An early feasibility study is a limited clinical investigation conducted when a medical device is still at an early stage of development. The FDA describes it as a way to assess initial clinical safety, basic functionality and whether the design concept works in people, often with a small number of participants.
For an implanted BCI, this may involve testing the surgical procedure, how well electrodes record signals, how participants use the system and whether early problems suggest that the device needs modification. Researchers closely supervise participants and may refine protocols as more is learned.
An early feasibility study is not designed to provide the same level of evidence as a pivotal trial. A promising result in a few selected people cannot establish population-wide effectiveness, long-term safety or eventual approval. The ability to adapt the design is one reason early studies can be valuable.
When you see an announcement about a first human implant or early-feasibility enrollment, check the actual study type, participant count, primary safety measures and duration of follow-up. Treat it as a development milestone, not as evidence that the device is ready for routine care.